Insider · CIK 0002008157
Hong Fang Song
director
Files at CGON (CG Oncology, Inc.). First filing Dec 17, 2024, latest Sep 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $22M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CGON: CG Oncology, Inc.
CGONOct 9, 2026 · close 63.82
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | CG Oncology, Inc. | $2.8M 100,000 shares | -3% | +84% from low-28% from high | |
| 53Moderate | CG Oncology, Inc. | $20M 700,000 shares | -19% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stockindirect: By Chaming Jade Limited10b5-1 | -69,695 | $27.60 | $1.9M | 2,934,236 | Sep 4, 2025 |
| Sep 3, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stockindirect: By Charming Jade Limited10b5-1 | -30,105 | $28.24 | $850k | 2,904,131 | Sep 4, 2025 |
| Sep 3, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stockindirect: By Charming Jade Limited10b5-1 | -100 | $28.96 | $2,896 | 2,904,031 | Sep 4, 2025 |
| Sep 3, 2025 | CGON CG Oncology, Inc. | SOpen-market sale Common Stockindirect: By Charming Jade Limited10b5-1 | -100 | $28.99 | $2,899 | 2,903,931 | Sep 4, 2025 |
| Jun 5, 2025 | CGON CG Oncology, Inc. | AGrant or award Director Stock Option (right to buy)derivative10b5-1 | +24,165 | $0.00 | $0 | 24,165 | Jun 6, 2025 |
| Dec 16, 2024 | CGON CG Oncology, Inc. | SOpen-market sale Common Stockindirect: By Charming Jade Limited | -700,000 | $28.00 | $20M | 3,003,931 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.